Centre François Baclesse
About Centre François Baclesse
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Centre Francois Baclesse
85
UNICANCER
82
Hoffmann-La Roche
26
Centre Oscar Lambret
22
Centre Leon Berard
19
European Organisation for Research and Treatment of Cancer - EORTC
19
ARCAGY/ GINECO GROUP
17
Intergroupe Francophone de Cancerologie Thoracique
16
Institut Claudius Regaud
10
The Lymphoma Academic Research Organisation
7
Federation Francophone de Cancerologie Digestive
6
Clinical Trials at Centre François Baclesse
During the past decade, Centre François Baclesse conducted 240 clinical trials. In the 10-year time frame, 240 clinical trials started and 47 clinical trials were completed, i.e. on
average, 19.6% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 21 clinical trials were completed. i.e. 24.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
1989-09-01
Active, not recruiting
615
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
1996-07-01
Completed
564
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
1993-03-01
Unknown status
280
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
1996-06-01
2010-10-01
Completed
1,400
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
1998-04-01
Completed
29
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre François Baclesse" #1 sponsor was "Centre Francois Baclesse" with 85 trials, followed by "UNICANCER" with 82 trials
sponsored, "Hoffmann-La Roche" with 26 trials sponsored, "Centre Oscar Lambret" with 22 trials sponsored and "Centre Leon Berard"
with 22 trials sponsored. Other sponsors include 255 different institutions and
companies that sponsored additional 114 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre François Baclesse"
#1 collaborator was "National Cancer Institute, France" with 26 trials as a collaborator, "AstraZeneca" with 18 trials as a collaborator, "Hoffmann-La Roche" with 11 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator and "Roche Pharma AG" with 9 trials as a collaborator. Other collaborators include 344 different institutions and companies that were
collaborators in the rest 227 trials.
Clinical Trials Conditions at Centre François Baclesse
According to Clinical.Site data, the most researched conditions in "Centre François Baclesse" are
"Breast Cancer" (61 trials), "Ovarian Cancer" (21 trials), "Prostate Cancer" (18 trials), "Cancer" (17 trials) and "Head and Neck Cancer" (12 trials). Many other conditions were trialed in "Centre François Baclesse" in a lesser frequency.
Clinical Trials Intervention Types at Centre François Baclesse
Most popular intervention types in "Centre François Baclesse" are "Drug" (332 trials), "Other" (80 trials), "Radiation" (58 trials), "Procedure" (38 trials) and "Biological" (34 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (29 trials), "Paclitaxel" (23 trials), "Bevacizumab" (22 trials), "Carboplatin" (18 trials) and "fluorouracil" (16 trials). Other intervention names were less common.
Clinical Trials Genders at Centre François Baclesse
The vast majority of trials in "Centre François Baclesse" are
330 trials for "All" genders, 127 trials for "Female" genders and 37 trials for "Male" genders.
Clinical Trials Status at Centre François Baclesse
Currently, there are NaN active trials in "Centre François Baclesse".
5 are not yet recruiting,
100 are recruiting,
82 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 232 completed trials in Centre François Baclesse,
1 suspended trials,
and 47 terminated clinical trials to date.
Out of the total trials that were conducted in Centre François Baclesse, 24 "Phase 1"
clinical trials were conducted, 188 "Phase 2" clinical
trials and 175 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 82 trials that are defined as “Not Applicable".
Departments of Centre François Baclesse
Centre François Baclesse has several departments that took part in Clinical trials: "Centre Francois Baclesse; Urologie Gynecologie" - 3 trials
Departments List
Name
City
Trials